CM Hospitalar S.A., which operates under the Viveo brand (VVEO3), reported this Tuesday, October 27, 2026, that, as part of the capital increase approved on June 26, 2026, 963,584,966 new common shares were preliminarily subscribed, totaling R$ 867,226,469.40, corresponding to 99.71% of the maximum amount of the capital increase of up to R$ 869,761,072.80.
During the subscription period for remaining shares, from September 9 to October 26, 2026, 7,063,994 new shares were subscribed, totaling R$ 6,357,594.60. After this stage, 258,956,069 shares remained available to meet requests for additional leftover shares, of which 256,139,843 shares were effectively allocated, in the total amount of R$ 230,525,858.70, with no need for apportionment.
Considering all phases of the process, preemptive rights accounted for the subscription of 700,381,129 shares, in the amount of R$ 630,343,016.10, while leftovers and additional leftovers totaled 263,203,837 shares. A total of 2,816,226 shares remained unsubscribed, equivalent to 0.29% of the maximum amount, which will not be issued, and there will be no auction of leftover shares.
The company also reported that the shares related to leftovers and additional leftovers will be paid up in Brazilian currency, in a single installment, or through the capitalization of credits held against the company, as previously disclosed. The quantities and amounts reported are preliminary and assume full settlement of these subscriptions and may be adjusted due to conditional subscriptions.
The estimated schedule provides for the settlement of leftovers and additional leftovers on October 29, 2026, and a meeting of the Board of Directors on October 30, 2026, to deliberate on the ratification of the capital increase. Viveo also expects the start of trading of the new shares on November 3, 2026, and the update of positions in the Central Securities Depository, with the conversion of subscription receipts into shares and the refund of amounts from conditional subscriptions, on November 4, 2026, dates that will be confirmed in a new notice to shareholders.
